1. Home
  2. IMCC vs GXAI Comparison

IMCC vs GXAI Comparison

Compare IMCC & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCC
  • GXAI
  • Stock Information
  • Founded
  • IMCC 1980
  • GXAI 2021
  • Country
  • IMCC Israel
  • GXAI United States
  • Employees
  • IMCC N/A
  • GXAI N/A
  • Industry
  • IMCC Medicinal Chemicals and Botanical Products
  • GXAI
  • Sector
  • IMCC Health Care
  • GXAI
  • Exchange
  • IMCC Nasdaq
  • GXAI Nasdaq
  • Market Cap
  • IMCC 7.5M
  • GXAI 7.5M
  • IPO Year
  • IMCC N/A
  • GXAI 2023
  • Fundamental
  • Price
  • IMCC $2.37
  • GXAI $1.53
  • Analyst Decision
  • IMCC
  • GXAI
  • Analyst Count
  • IMCC 0
  • GXAI 0
  • Target Price
  • IMCC N/A
  • GXAI N/A
  • AVG Volume (30 Days)
  • IMCC 17.6K
  • GXAI 721.7K
  • Earning Date
  • IMCC 03-27-2025
  • GXAI 03-26-2025
  • Dividend Yield
  • IMCC N/A
  • GXAI N/A
  • EPS Growth
  • IMCC N/A
  • GXAI N/A
  • EPS
  • IMCC N/A
  • GXAI N/A
  • Revenue
  • IMCC $38,042,859.00
  • GXAI $2,979.00
  • Revenue This Year
  • IMCC $22.59
  • GXAI N/A
  • Revenue Next Year
  • IMCC $32.86
  • GXAI N/A
  • P/E Ratio
  • IMCC N/A
  • GXAI N/A
  • Revenue Growth
  • IMCC N/A
  • GXAI N/A
  • 52 Week Low
  • IMCC $1.44
  • GXAI $1.01
  • 52 Week High
  • IMCC $8.10
  • GXAI $19.20
  • Technical
  • Relative Strength Index (RSI)
  • IMCC 53.35
  • GXAI 40.09
  • Support Level
  • IMCC $2.05
  • GXAI $1.35
  • Resistance Level
  • IMCC $2.60
  • GXAI $2.22
  • Average True Range (ATR)
  • IMCC 0.21
  • GXAI 0.15
  • MACD
  • IMCC 0.02
  • GXAI -0.03
  • Stochastic Oscillator
  • IMCC 58.31
  • GXAI 19.54

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.

Share on Social Networks: